CN102317431A - 控制动物疾病的组合物和方法 - Google Patents
控制动物疾病的组合物和方法 Download PDFInfo
- Publication number
- CN102317431A CN102317431A CN200980156462XA CN200980156462A CN102317431A CN 102317431 A CN102317431 A CN 102317431A CN 200980156462X A CN200980156462X A CN 200980156462XA CN 200980156462 A CN200980156462 A CN 200980156462A CN 102317431 A CN102317431 A CN 102317431A
- Authority
- CN
- China
- Prior art keywords
- animal
- compsn
- weight
- diseases
- foodstuff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Food Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Husbandry (AREA)
- Medical Informatics (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
Abstract
Description
处理 | 坏死性肠炎损害评分 | 坏死性肠炎死亡率% |
对照 | 0 | 0 |
攻击对照 | 1.11 | 20.83 |
AlCare 0.5 | 0.56 | 6.25 |
AlCare 1 | 0.56 | 6.25 |
Alphamune 1 | 0.72 | 10.42 |
Alphamune 2 | 0.94 | 12.50 |
AlCare 0.5+Alphamune 1 | 0.44 | 12.50 |
AlCare 1+Alphamune 1 | 0.28 | 2.08 |
AlCare 0.5+Alphamune 2 | 0.72 | 10.42 |
AlCare 1+Alphamune 2 | 0.56 | 6.25 |
Claims (48)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12125808P | 2008-12-10 | 2008-12-10 | |
US61/121,258 | 2008-12-10 | ||
US15690209P | 2009-03-03 | 2009-03-03 | |
US61/156,902 | 2009-03-03 | ||
US18731609P | 2009-06-16 | 2009-06-16 | |
US61/187,316 | 2009-06-16 | ||
PCT/US2009/005303 WO2010068231A1 (en) | 2008-12-10 | 2009-09-24 | Compositions and methods for controlling disease in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102317431A true CN102317431A (zh) | 2012-01-11 |
Family
ID=42231342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980156462XA Pending CN102317431A (zh) | 2008-12-10 | 2009-09-24 | 控制动物疾病的组合物和方法 |
Country Status (12)
Country | Link |
---|---|
US (3) | US8227235B2 (zh) |
EP (1) | EP2376618A4 (zh) |
JP (1) | JP5645843B2 (zh) |
KR (2) | KR20130108664A (zh) |
CN (1) | CN102317431A (zh) |
AU (1) | AU2009325106A1 (zh) |
BR (1) | BRPI0922323A8 (zh) |
CA (1) | CA2745381A1 (zh) |
CL (1) | CL2014000894A1 (zh) |
MX (1) | MX2011006256A (zh) |
WO (1) | WO2010068231A1 (zh) |
ZA (1) | ZA201104062B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105008525A (zh) * | 2013-02-27 | 2015-10-28 | Cj第一制糖株式会社 | 新颖噬菌体和包括其的抗细菌组合物 |
CN111801020A (zh) * | 2018-02-02 | 2020-10-20 | 诺维信公司 | 致病性劳森菌属的管理 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2527673T3 (es) * | 2008-09-17 | 2015-01-28 | Bayer Cropscience Lp | Procedimiento para usar una cepa de Bacillus subtilis para potenciar la salud animal |
WO2011116155A1 (en) | 2010-03-17 | 2011-09-22 | Agraquest, Inc. | Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions |
EP2593187A4 (en) * | 2010-07-16 | 2014-04-09 | Univ Arkansas | METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH |
WO2012044984A1 (en) | 2010-09-30 | 2012-04-05 | The Board Of Trustees Of The University Of Arkansas | Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads |
WO2014022572A1 (en) | 2012-08-01 | 2014-02-06 | Pacific Vet Group-Usa, Inc. | Probiotic for amelioration of coccidiosis vaccine reaction |
GB201213801D0 (en) | 2012-08-03 | 2012-09-12 | Dupont Nutrition Biosci Aps | Feed additive composition |
DK2958437T3 (da) * | 2013-02-21 | 2020-03-30 | Direvo Ind Biotechnology Gmbh | Præbiotiske dyrefoderprodukter |
US9694044B2 (en) | 2014-09-22 | 2017-07-04 | Global Nutritech Biotechnology Llc | Thermo-modified nutshells and methods of treating diarrhea, adsorbing toxins, promoting growth and improving the overall health |
CN104546739A (zh) * | 2015-01-20 | 2015-04-29 | 山西新源华康化工股份有限公司 | 一种盐霉素的提取工艺 |
CN110430763A (zh) * | 2017-03-07 | 2019-11-08 | 国际生物资源有限公司 | 饲料添加剂配方及其制备和使用方法 |
CN107836585A (zh) * | 2017-12-26 | 2018-03-27 | 湖南农业大学 | 一种提高母猪泌乳性能和抗氧化能力的饲料添加剂及其制备方法 |
KR102207354B1 (ko) * | 2019-09-02 | 2021-01-27 | (주)제이비바이오텍 | CRISPR/Cas9 기반 Bacillus subtilis 유전체 편집 메커니즘을 이용한 닭의 괴사성장염 백신 |
US20210252078A1 (en) * | 2019-09-16 | 2021-08-19 | Microbiome Labs, Llc | Spore-based probiotic supplementation in chickens and effect on salmonella loads |
FR3138028A1 (fr) * | 2022-07-20 | 2024-01-26 | Lesaffre Et Compagnie | Extrait de Parois Cellulaires de Levure Saccharomyces Cerevisiae Riche en β-Glucanes dans la Prévention ou le Traitement d’une maladie associée ou causée par une infection à Lawsonia intracellularis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649143A (en) * | 1984-03-26 | 1987-03-10 | American Cyanamid Company | Methods and compositions for treating protozoal infections with a novel antibiotic |
US6214337B1 (en) * | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
US20060276339A1 (en) * | 2002-10-16 | 2006-12-07 | Windsor J B | Methods and compositions for increasing the efficacy of biologically-active ingredients |
CN101076585A (zh) * | 2003-08-14 | 2007-11-21 | 生物平衡公司 | 细菌株系、包括该细菌株系的组合物和其益生菌用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA59394C2 (uk) * | 1998-03-27 | 2003-09-15 | Каділа Фармацевтікелс (І.Ей) Лтд. | Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти) |
AU2001272369A1 (en) * | 2000-07-17 | 2002-01-30 | Chr. Hansen A/S | Methods and formultations with probiotic microorganisms and medicaments |
-
2009
- 2009-09-21 US US12/586,359 patent/US8227235B2/en active Active
- 2009-09-24 BR BRPI0922323A patent/BRPI0922323A8/pt not_active IP Right Cessation
- 2009-09-24 MX MX2011006256A patent/MX2011006256A/es active IP Right Grant
- 2009-09-24 WO PCT/US2009/005303 patent/WO2010068231A1/en active Application Filing
- 2009-09-24 KR KR1020137020766A patent/KR20130108664A/ko active IP Right Grant
- 2009-09-24 JP JP2011540677A patent/JP5645843B2/ja not_active Expired - Fee Related
- 2009-09-24 EP EP09832216A patent/EP2376618A4/en not_active Withdrawn
- 2009-09-24 CA CA2745381A patent/CA2745381A1/en not_active Abandoned
- 2009-09-24 AU AU2009325106A patent/AU2009325106A1/en not_active Abandoned
- 2009-09-24 CN CN200980156462XA patent/CN102317431A/zh active Pending
- 2009-09-24 KR KR1020117015679A patent/KR20110093940A/ko active Application Filing
-
2011
- 2011-06-01 ZA ZA2011/04062A patent/ZA201104062B/en unknown
-
2012
- 2012-06-08 US US13/491,702 patent/US20120244191A1/en not_active Abandoned
-
2013
- 2013-08-22 US US13/973,327 patent/US20130337014A1/en not_active Abandoned
-
2014
- 2014-04-09 CL CL2014000894A patent/CL2014000894A1/es unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649143A (en) * | 1984-03-26 | 1987-03-10 | American Cyanamid Company | Methods and compositions for treating protozoal infections with a novel antibiotic |
US6214337B1 (en) * | 1995-04-18 | 2001-04-10 | Biotec Asa | Animal feeds comprising yeast glucan |
US20060276339A1 (en) * | 2002-10-16 | 2006-12-07 | Windsor J B | Methods and compositions for increasing the efficacy of biologically-active ingredients |
CN101076585A (zh) * | 2003-08-14 | 2007-11-21 | 生物平衡公司 | 细菌株系、包括该细菌株系的组合物和其益生菌用途 |
Non-Patent Citations (7)
Title |
---|
G.HUYGHEBAERT: "Alternatives Antibiotics In Poultry", 《PROCEEDINGS 3RD MID-ATLANTIC NUTRITION CONFERENCE》 * |
吕艳春: "微量饲料添加剂载体的选择和使用", 《中国饲料》 * |
吴绍强等: "鸡球虫疫苗研究进展", 《畜牧兽医学报》 * |
徐春厚等: "《微生物饲料与添加剂》", 31 March 2000 * |
林维庆: "坏死性肠炎与球虫病", 《中国饲料》 * |
芮艺等: "禽坏死性肠炎的控制", 《中国家禽》 * |
邵明丽等: "酵母细胞壁对动物机体的免疫作用及其作用机理", 《饲料研究》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105008525A (zh) * | 2013-02-27 | 2015-10-28 | Cj第一制糖株式会社 | 新颖噬菌体和包括其的抗细菌组合物 |
US9745555B2 (en) | 2013-02-27 | 2017-08-29 | Cj Cheiljedang Corporation | Bacteriophage and antibacterial composition comprising the same |
CN111801020A (zh) * | 2018-02-02 | 2020-10-20 | 诺维信公司 | 致病性劳森菌属的管理 |
CN111801020B (zh) * | 2018-02-02 | 2024-04-26 | 诺维信公司 | 致病性劳森菌属的管理 |
Also Published As
Publication number | Publication date |
---|---|
CL2014000894A1 (es) | 2014-11-21 |
US20120244191A1 (en) | 2012-09-27 |
ZA201104062B (en) | 2012-08-29 |
JP5645843B2 (ja) | 2014-12-24 |
KR20110093940A (ko) | 2011-08-18 |
EP2376618A4 (en) | 2013-02-13 |
MX2011006256A (es) | 2011-09-27 |
BRPI0922323A8 (pt) | 2017-10-31 |
EP2376618A1 (en) | 2011-10-19 |
US20130337014A1 (en) | 2013-12-19 |
KR20130108664A (ko) | 2013-10-04 |
US8227235B2 (en) | 2012-07-24 |
CA2745381A1 (en) | 2010-06-17 |
BRPI0922323A2 (pt) | 2017-06-06 |
AU2009325106A1 (en) | 2010-06-17 |
US20100143417A1 (en) | 2010-06-10 |
WO2010068231A1 (en) | 2010-06-17 |
JP2012511572A (ja) | 2012-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102317431A (zh) | 控制动物疾病的组合物和方法 | |
Islam et al. | Efficacy of mealworm and super mealworm larvae probiotics as an alternative to antibiotics challenged orally with Salmonella and E. coli infection in broiler chicks | |
US11291695B2 (en) | Bacillus subtilis strains improving animal performance parameters | |
Jin et al. | Influence of dried Bacillus substillis and lactobacilli cultures on intestinal microflora and performance in broilers | |
Ahmed et al. | Comparison of single and blend acidifiers as alternative to antibiotics on growth performance, fecal microflora, and humoral immunity in weaned piglets | |
US11331351B2 (en) | Bacillus strains improving health and performance of production animals | |
CN111032063A (zh) | 酵母和细菌益生菌的组合以及用于改善猪的生产的方法 | |
WO2015160960A1 (en) | System and method for production of shelf stable probiotics for animal nutrition enhancement | |
KR101025810B1 (ko) | 곤충을 이용한 항생제 대체용 비분해성 사료첨가제 및 이의 제조방법 | |
Chen et al. | Effects of Armillariella tabescens mycelia on the growth performance and intestinal immune response and microflora of early‐weaned pigs | |
CN108185148A (zh) | 一种改善断奶兔腹泻的易加工复合预混料 | |
JP2021516258A (ja) | 動物における大腸菌(E.coli)に基づく感染症の予防及び/又は処置での直接給与微生物の使用 | |
Javadi et al. | Effects of probiotic (live and inactive Saccharomyces cerevisiae) on meat and intestinal microbial properties of Japanese quails | |
Noh et al. | Effects of citrus pulp, fish by-product and Bacillus subtilis fermentation biomass on growth performance, nutrient digestibility, and fecal microflora of weanling pigs | |
JP7092785B2 (ja) | 飼料添加物製剤ならびにその製造方法および使用方法 | |
KR20200072694A (ko) | 베타-글루쿠로니다제 분비 활성을 가진 락토바실러스 파라카제이 균주, 이를 이용한 황금 발효물 및 사료 첨가제 | |
Abu et al. | Pellet Versus marsh: assessing the impact of feed forms on growth performance, nutrient digestibility, carcass characteristics and health of broiler chickens–A Review | |
Dumitru et al. | The beneficial effect of Bacillus spp. as probiotics in poultry nutrition-a review. | |
Lei et al. | Growth performance, nutrient digestibility, and selected fecal microbiota are improved by β-glucan supplementation in weaner pigs | |
US8673290B2 (en) | Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof | |
RU2266747C1 (ru) | Пробиотическая композиция для животных и птицы | |
Rahmatian et al. | Investigation of oocyst count and performance affected by butyric acid and salinomysin in broiler | |
Botlhoko | Performance of Clostridium perfringens-challenged broilers inoculated with Effective Microorganisms | |
Вели | All-Russian Research Veterinary Institute of Pathology, Pharmacology and Therapy BACTERIOCIN PRODUCTION AS A MECHANISM FOR THE ANTI-INFECTIVE ACTIVITY OF LACTOBACILLUS SALIVARIUS UCC118 | |
Rashid et al. | International Journal of Veterinary Science |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: new jersey Applicant after: Alpharma Inc. Address before: Delaware Applicant before: Alpharma Inc. |
|
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1161293 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: new jersey Applicant after: Zottis products limited liability company Address before: new jersey Applicant before: Alpharma Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: ALPHARMA, LLC TO: ZOTIS PRODUCTS CO., LTD. |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120111 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1161293 Country of ref document: HK |